Icrea/UPF and Acellera
Session 1: The impact of AI-based tools and data science in Drug Discovery
Talk: Impact of AI and physics-based drug discovery at Acellera
Almirall
Session 1: The impact of AI-based tools and data science in Drug Discovery
Talk: AI (r?)evolution. Have we learned from past waves of (r?)evolutionary technologies?
Universidad Politécnica de Madrid (UPM)
Session 1: The impact of AI-based tools and data science in Drug Discovery
Talk: Predicting drug-target interactions with deep learning models
Bellvitge Biomedical Research Institute (IDIBELL) and Catalan Institute of Oncology (ICO)
Session 1: The impact of AI-based tools and data science in Drug Discovery
Talk: Harnessing AI in Drug Discovery & Development: Mind your Data
Head of R&D Operations & Head of Spain, Agomab Therapeutics
Session 2: Drug Discovery projects in public – private collaborations
Talk: From Origo to Agomab, an ongoing success story
Professor at University of Santiago de Compostela
Session 2: Drug Discovery projects in public – private collaborations
Talk: Creating value in Drug Discovery trough Public Private Partnerships
Skills lead, Innovation Hubs for Gene Therapies/ Senior Business Manager, LifeArc
Session 2: Drug Discovery projects in public – private collaborations
Talk: From Bench to Bedside: The Value of Promising Translational Research
Welab Barcelona
Session 2:Drug Discovery projects in public – private collaborations
Talk: From open innovation to joint public – private pharmaceutical R&D
Hospital Vall d'Hebrón
Session 3: Using patient omics for the discovery of personalized medicines
Talk: Precision oncology from a European perspective
DTU Biosustani Research Center
Session 3: Using patient omics for the discovery of personalized medicines
Talk: The Power of Graph Structures to Integrate, Analyze and Interpret Multi-omics Data
Plasma R&D, Scientific Innovation Office, Grifols, Barcelona, Spain
Session 3:Using patient omics for the discovery of personalized medicines
Talk:“Longitudinal omics data analysis of patients undergoing therapeutic plasma exchange with albumin replacement as a treatment for Alzheimer’s Disease”
Universitat Rovira i Virgili (URV)
Session 3: Using patient omics for the discovery of personalized medicines
Talk: Advancing metabolomics technologies for drug discovery and development
CIEMAT
Session 4: Advanced Cell and Gene Therapies
Talk: Gene Therapy for Inherited Anemias: From Lentiviral to Gene Editing Strategies
Senior Vicepresident, Medical Affairs. Forge Biologics
Session 4: Advanced Cell and Gene Therapies
Talk:Gene Therapy for Krabbe Disease
Hospital La Paz
Session 4: Advanced Cell and Gene Therapies
Talk: CAR-T cells engineering with NK cell properties
Laboratorio de Inmuno-Regulación. Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Session 4: Advanced Cell and Gene Therapies
Talk: Advanced cell therapy with Treg cells obtained from thymic tissue (thyTreg). A new paradigm in the treatment of inflammatory diseases
